Skip to content
Open access

Association Between the Triglyceride-Glucose Index and Clinical Outcomes Modified by Diabetes Duration in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Sep 2026 · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · Vol 19 · 0 citations · 36 references
Medicine

TL;DR

A higher TyG index was independently associated with an increased risk of ischemic events and mortality among patients with ACS and T2DM, and this association appeared to be attenuated with longer diabetes duration, suggesting that the prognostic relevance of the TyG index may vary according to the chronicity of diabetes.

Abstract

Background An elevated triglyceride-glucose (TyG) index is strongly linked to an increased risk of cardiovascular events in patients with acute coronary syndrome (ACS) and type 2 diabetes mellitus (T2DM). However, the potential impact of increasing diabetes duration on the association between the TyG index and cardiovascular risk remains unclear. Methods Consecutive patients admitted for ACS with T2DM received PCI between March 2016 and March 2020 were enrolled in the analysis. A total of 7093 patients were categorized into tertiles according to the TyG index and T2DM duration. The primary outcome was ischemic events, composed of cardiac death, myocardial infarction, and/or stroke at 5 years. The main secondary outcomes were 5-year cardiac death and all-cause death. Interaction terms and non-linear associations of the TyG index with the clinical outcomes were examined across diabetes durations. Results Over 5 years, 753 (10.6%) experienced ischemic events, 375 (5.3%) cardiac death, and 636 (9.0%) all-cause death. Higher TyG index and longer diabetes duration independently associated with all outcomes. Compared with the lowest TyG tertile, the highest tertile had adjusted hazard ratios (HRs) of 1.55 (95% CI: 1.29–1.88) for ischemic events and 1.23 (1.10–1.38) for all-cause death. The association between TyG index and ischemic events was strongest in the shortest duration group (HR: 1.43), with significant interaction for ischemic and cardiac death (both p < 0.05). Conclusions A higher TyG index was independently associated with an increased risk of ischemic events and mortality among patients with ACS and T2DM. This association appeared to be attenuated with longer diabetes duration, suggesting that the prognostic relevance of the TyG index may vary according to the chronicity of diabetes.

Read PDF

Similar papers

Review Aug 2026

The long-term prognostic value of triglyceride-glucose index in type 2 diabetics without clinical coronary artery disease.

In a cohort without known CAD, baseline TyG independently predicts long-term MACE in T2DM, and this simple, widely available metabolic marker may enhance cardiovascular risk stratification and MACE primary prevention strategies.

Yuval Avidan, D. Halon, Amir Yahav et al. · 0 citations
Open access Oct 2026

Association between the triglyceride-glucose index and functional outcome at discharge in patients receiving standardized treatment for atherosclerotic and cardioembolic stroke

The triglyceride-glucose (TyG) index is gaining considerable attention as an emerging marker of metabolic syndrome. The TyG index is strongly associated with atherosclerosis and cardiovascular disease development. However, the impact of the TyG index on the functional outcome at discharge of patients receiving stan...

Ni-Ni Zhu, Wen Zhong, Xiao-Zhu Shen et al. · 0 citations
Open access Aug 2026

Triglyceride-glucose index is associated with the severity of coronary artery disease

Cardiovascular disease(CVD) remains a leading cause of mortality worldwide. Among CVDs, coronary heart disease (CHD) is the most prevalent and represents the primary contributor to chronic disease-related deaths globally. The triglyceride-glucose (TyG) index has been shown to correlate significantly with both mortality...

Di Wang, Ying Wang, Fangfang Li et al. · 0 citations
Open access Aug 2026

Association of Triglyceride–Glucose Index with Heart Failure with Preserved Ejection Fraction and Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

Background: Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a major cardiovascularcomplication in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a central role in the pathogenesis ofHFpEF, and the triglyceride–glucose (TyG) index has emerged as a simple surr...

V. Kavya, Akshaya Kamalashree G, B. V. P. Karthik et al. · 0 citations
Open access Aug 2026

Effects of statins on glycemic control and cardiovascular events in patients with new-onset type 2 diabetes: a retrospective cohort study

In patients with new-onset T2D, early statin initiation is associated with worse short-term glycemic improvement and a greater need for escalating glucose-lowering therapy; however, it is also associated with a substantial reduction in the long-term MACE risk.

Ying Ran, Li-Li Jiang, Jing Ran et al. · 0 citations
Open access Aug 2026

Association of Systemic Inflammatory and Metabolic Biomarkers with Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes: A Prospective Cohort Study

A combined inflammatory–metabolic profile identified patients with T2DM who experienced subsequent cardiovascular events and may provide complementary information when used alongside standard cardiovascular risk assessment.

Ahmad Azhar, Yousaf Khan, Muhammad Huzaifa · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.